<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01542645</url>
  </required_header>
  <id_info>
    <org_study_id>ENH10-256</org_study_id>
    <nct_id>NCT01542645</nct_id>
  </id_info>
  <brief_title>The Effect of Choice of Intraoperative Opioid on Postoperative Pain</brief_title>
  <official_title>The Effect of Choice of Intraoperative Opioid on Postoperative Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NorthShore University HealthSystem Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NorthShore University HealthSystem Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this randomized, double-blind study is to examine the effect of a single
      intraoperative dose of methadone on postoperative pain and analgesic requirements in patients
      undergoing cardiac surgery with cardiopulmonary bypass. These patients will be compared to
      subjects receiving a standard dose of the &quot;traditional&quot; intraoperative opioid (fentanyl).
      Secondary outcome measures to be assessed will include standard recovery variables (such as
      length of postoperative intubation, ICU length of stay, incidence of nausea or vomiting,
      level of sedation). In addition, patients will be assessed for the development of chronic
      postoperative pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be randomized to receive either methadone or fentanyl on the basis of a
      computer generated random number table. Patients in each group will receive standard
      intraoperative doses of either methadone or fentanyl that will allow for early tracheal
      extubation (within 4-8 hours of the conclusion of the surgical procedure). Study infusions
      will be prepared by the pharmacy, and all clinicians will be blinded to group assignment
      (methadone group-0.3 mg/kg-100 mL normal saline; fentanyl group-12 Î¼g/kg-100 mL normal
      saline).

      Pain will be assessed by blinded observers using a 11-point verbal analogue scale (0=no pain,
      10=worst pain imaginable). Assessment for pain will be performed 15 minutes post-extubation
      and then 2, 4, 8, 12, 24, 48, and 72 hours after tracheal extubation. Pain will be determined
      at rest, with coughing, and during movement. At the same time pain data is collected, several
      other clinical assessments will be completed. The presence or absence of nausea and vomiting
      will be determined, and severity quantified using a 4-point ordinal scale (0=none, 3=severe).
      Level of sedation will be measured by observers using a 4-point sedation scale (0=fully
      awake, 1=mildly sedated (seldom drowsy and easy to awake), 2=moderately sedated (often drowsy
      and easy to awake), 3=severely sedated (somnolent, difficult to awake). Pruritis will also be
      measured using a 4-point scale (0=none, 3=severe). Any episodes of hypoventilation
      (respiratory rate &lt; 8 breaths/min) or hypoxemia (oxygen saturation &lt; 90%) during the study
      period will be recorded. Patient satisfaction with overall pain management will be determined
      using a 100-point verbal rating scale (1=highly dissatisfied (worst), 100=highly satisfied
      (best)). Respiratory rate, oxygen saturation (in ICU), and mean arterial blood pressure at
      the time of evaluation will be noted.

      Postoperative pain will be managed according to standard institutional protocols. In the ICU,
      intravenous morphine will be administered for initial pain management (1 mg for mild-moderate
      pain, 2 mg for moderate-severe pain). Patients will be transitioned to oral pain medication
      when oral intake is tolerated (Norco tablets). The amount of pain medication administered
      during each study interval (listed above) will be recorded.

      Other standard recovery variables will be recorded. These include time of initiation of
      ventilator weaning, time of tracheal extubation, arterial blood gas following extubation,
      time of ICU discharge, and time of hospital discharge. Time of first flatus and bowel
      movement will be recorded. Any complications during the hospitalization will be recorded. In
      a cohort of patients undergoing only coronary artery bypass graft surgery (n=75), serum
      troponins will be measured postoperatively to determine whether methadone has a potential
      cardioprotective effect.

      Patients will be provided with a survey and self-addressed envelope following discharge from
      the hospital to determine the presence or absence of chronic persistent surgical pain. These
      data will be mailed by each patient 1, 3, 6, and 12 months postoperatively. The survey will
      assess the nature and severity of pain related to the surgical procedure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Opioid Consumption in the Postoperative Period</measure>
    <time_frame>First 3 days after surgery</time_frame>
    <description>Total intravenous morphine used first three days (72 hours after ICU admission)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative Pain Scores</measure>
    <time_frame>2 hours after cardiac surgery</time_frame>
    <description>Pain was assessed on a 11-point verbal analogue scale with 0=no pain, 10=worst pain imaginable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic Postoperative Pain Scores</measure>
    <time_frame>1,3,6, and 12 months after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Marker of Myocardial Injury (Troponin I)</measure>
    <time_frame>12 hours after surgery</time_frame>
    <description>In a cohort of patients undergoing only coronary artery bypass graft surgery (n=75), serum troponins will be measured postoperatively to determine whether methadone has a potential cardioprotective effect.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">164</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Methadone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Long-acting opioid</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fentanyl</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Shorter-acting opioid</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methadone</intervention_name>
    <description>Methadone (0.3 mg/kg) will be administered intraoperatively, with half of the dose given at induction of anesthesia (over 5 minutes) and the remainder administered as an infusion over the next 2 hours.</description>
    <arm_group_label>Methadone</arm_group_label>
    <other_name>opioid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl</intervention_name>
    <description>Fentanyl (12 mcg/kg) will be administered intraoperatively, with half of the dose given at induction of anesthesia (over 5 minutes) and the remainder administered as an infusion over the next 2 hours.</description>
    <arm_group_label>Fentanyl</arm_group_label>
    <other_name>opioid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients presenting for elective cardiac surgery with CPB will be eligible for
             enrollment.

        Exclusion Criteria:

          1. Preoperative renal failure requiring dialysis

          2. Significant hepatic dysfunction (liver function tests &gt; 2 times upper normal limit)

          3. Preoperative ejection fraction &lt; 30%

          4. Pulmonary disease necessitating home oxygen therapy

          5. Preoperative requirement for inotropic agents or intraaortic balloon pump to maintain
             hemodynamic stability

          6. Allergy to methadone or fentanyl

          7. Preoperative pain, use of preoperative opioids, or recent history of opioid abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Glenn S. Murphy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NorthShore University HealthSystem</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NorthShore University HealthSystem</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2012</study_first_submitted>
  <study_first_submitted_qc>March 1, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2012</study_first_posted>
  <results_first_submitted>March 26, 2014</results_first_submitted>
  <results_first_submitted_qc>April 25, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 26, 2014</results_first_posted>
  <last_update_submitted>September 23, 2014</last_update_submitted>
  <last_update_submitted_qc>September 23, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 2, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>NorthShore University HealthSystem Research Institute</investigator_affiliation>
    <investigator_full_name>Glenn S. Murphy, MD</investigator_full_name>
    <investigator_title>Director, Cardiac Anesthesia and clinical Research</investigator_title>
  </responsible_party>
  <keyword>Fentanyl</keyword>
  <keyword>Methadone</keyword>
  <keyword>Thoracic Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Chronic Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics, Opioid</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Methadone</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Methadone</title>
          <description>Methadone: Methadone (0.3 mg/kg) will be administered intraoperatively, with half of the dose given at induction of anesthesia (over 5 minutes) and the remainder administered as an infusion over the next 2 hours.</description>
        </group>
        <group group_id="P2">
          <title>Fentanyl</title>
          <description>Fentanyl: Fentanyl (12 mcg/kg) will be administered intraoperatively, with half of the dose given at induction of anesthesia (over 5 minutes) and the remainder administered as an infusion over the next 2 hours.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="82"/>
                <participants group_id="P2" count="82"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="77"/>
                <participants group_id="P2" count="79"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Methadone</title>
          <description>Methadone: Methadone (0.3 mg/kg) will be administered intraoperatively, with half of the dose given at induction of anesthesia (over 5 minutes) and the remainder administered as an infusion over the next 2 hours.</description>
        </group>
        <group group_id="B2">
          <title>Fentanyl</title>
          <description>Fentanyl: Fentanyl (12 mcg/kg) will be administered intraoperatively, with half of the dose given at induction of anesthesia (over 5 minutes) and the remainder administered as an infusion over the next 2 hours.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="77"/>
            <count group_id="B2" value="79"/>
            <count group_id="B3" value="156"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.7" spread="10.5"/>
                    <measurement group_id="B2" value="65.5" spread="11.1"/>
                    <measurement group_id="B3" value="65.1" spread="10.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                    <measurement group_id="B2" value="63"/>
                    <measurement group_id="B3" value="115"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Total Opioid Consumption in the Postoperative Period</title>
        <description>Total intravenous morphine used first three days (72 hours after ICU admission)</description>
        <time_frame>First 3 days after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Methadone</title>
            <description>Methadone: Methadone (0.3 mg/kg) will be administered intraoperatively, with half of the dose given at induction of anesthesia (over 5 minutes) and the remainder administered as an infusion over the next 2 hours.</description>
          </group>
          <group group_id="O2">
            <title>Fentanyl</title>
            <description>Fentanyl: Fentanyl (12 mcg/kg) will be administered intraoperatively, with half of the dose given at induction of anesthesia (over 5 minutes) and the remainder administered as an infusion over the next 2 hours.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Opioid Consumption in the Postoperative Period</title>
          <description>Total intravenous morphine used first three days (72 hours after ICU admission)</description>
          <units>milligrams</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="77"/>
                <count group_id="O2" value="79"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="0" upper_limit="44"/>
                    <measurement group_id="O2" value="14" lower_limit="2" upper_limit="146"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Pain Scores</title>
        <description>Pain was assessed on a 11-point verbal analogue scale with 0=no pain, 10=worst pain imaginable</description>
        <time_frame>2 hours after cardiac surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Methadone</title>
            <description>Methadone: Methadone (0.3 mg/kg) will be administered intraoperatively, with half of the dose given at induction of anesthesia (over 5 minutes) and the remainder administered as an infusion over the next 2 hours.</description>
          </group>
          <group group_id="O2">
            <title>Fentanyl</title>
            <description>Fentanyl: Fentanyl (12 mcg/kg) will be administered intraoperatively, with half of the dose given at induction of anesthesia (over 5 minutes) and the remainder administered as an infusion over the next 2 hours.</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Pain Scores</title>
          <description>Pain was assessed on a 11-point verbal analogue scale with 0=no pain, 10=worst pain imaginable</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="77"/>
                <count group_id="O2" value="79"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="0" upper_limit="8"/>
                    <measurement group_id="O2" value="4.5" lower_limit="0" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Chronic Postoperative Pain Scores</title>
        <time_frame>1,3,6, and 12 months after surgery</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Marker of Myocardial Injury (Troponin I)</title>
        <description>In a cohort of patients undergoing only coronary artery bypass graft surgery (n=75), serum troponins will be measured postoperatively to determine whether methadone has a potential cardioprotective effect.</description>
        <time_frame>12 hours after surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Methadone</title>
          </group>
          <group group_id="O2">
            <title>Fentanyl</title>
          </group>
        </group_list>
        <measure>
          <title>Marker of Myocardial Injury (Troponin I)</title>
          <description>In a cohort of patients undergoing only coronary artery bypass graft surgery (n=75), serum troponins will be measured postoperatively to determine whether methadone has a potential cardioprotective effect.</description>
          <units>nanograms per millimeter</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="34"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.4" lower_limit="0.001" upper_limit="11.7"/>
                    <measurement group_id="O2" value="4.6" lower_limit="0.7" upper_limit="30.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 years</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Methadone</title>
          <description>Methadone: Methadone (0.3 mg/kg) will be administered intraoperatively, with half of the dose given at induction of anesthesia (over 5 minutes) and the remainder administered as an infusion over the next 2 hours.</description>
        </group>
        <group group_id="E2">
          <title>Fentanyl</title>
          <description>Fentanyl: Fentanyl (12 mcg/kg) will be administered intraoperatively, with half of the dose given at induction of anesthesia (over 5 minutes) and the remainder administered as an infusion over the next 2 hours.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="79"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="79"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Glenn Murphy, MD</name_or_title>
      <organization>NorthShore University HealthSystem</organization>
      <phone>847-570-2760</phone>
      <email>dgmurphy2@yahoo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

